Daily News Podcast

FDA approves Zephyr valves for emphysema


 

The Food and Drug Administration has approved the Zypher endobronchial valve system for patients with severs emphysema who are experiencing difficulty breathing. Also today, meth use is climbing alongside the opioid epidemic, pain remains after rheumatoid arthritis diagnosis, and higher RA biologic drug levels linked with more infections. Subscribe to the MDedge Daily News for today’s top news.

Recommended Reading

Galectin-3: A post-MI prognostic biomarker for our times
MDedge Infectious Disease
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Infectious Disease
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Infectious Disease
Patients going without as insulin prices skyrocket
MDedge Infectious Disease
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Infectious Disease
Opioids do more harm than good for musculoskeletal pain
MDedge Infectious Disease
Addiction: Veterans with pain, opioid use disorder
MDedge Infectious Disease
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Infectious Disease
Medicare beneficiaries are dying differently
MDedge Infectious Disease
Updated anthrax vaccine recommendations
MDedge Infectious Disease